ST45177901
ST45177901 is a CC chemokine receptor 4 (CCR4) antagonist. The combination of ST45177901 and Sorafenib (HY-10201) effectively inhibits the chemotaxis of Treg cells via the CCL22/CCL17-CCR4 signaling pathway, thereby significantly suppressing the growth and metastasis of tumor cells. ST45177901 is applicable to liver cancer research.
연구목적의 판매만을 진행합니다. 환자를 대상으로 한 판매는 하지 않습니다.
- CAS No.: 618865-88-6
- 화학식: C26H16ClN3O4S3
- 분자량:566.07
-
보관:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
|
CCR4 |
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
Chemical Information
-
CAS No. 618865-88-6
-
분자량 566.07
-
화학식 C26H16ClN3O4S3
-
SMILES
O=C(C1=C(C(N(C1C2=CC=CS2)C3=NN=C(SCC4=CC=C(C=C4)Cl)S3)=O)O)C5=CC6=C(C=CC=C6)O5
-
선적
Room temperature in continental US; may vary elsewhere.
-
보관
Please store the product under the recommended conditions in the Certificate of Analysis.
순도&문서
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)